GLP-1 medicines commonly cause stomach-related side effects such as nausea, vomiting, diarrhoea, and constipation, especially at the start of treatment and during dose escalation
Cagrilintide layers on a smoother, portion-control style of fullness that many users describe as gentler on the stomach than ramping a single GLP-1 ever higher
Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: An open labeled randomized comparative trial Indian J Dermatol
All study staff, participants, and parents/legal guardians were blinded to treatment group assignment
Lupus patients should be counselled to: Maintain adequate hydration , particularly if experiencing nausea, vomiting, or diarrhoea, as dehydration poses particular risks for those with kidney involvement Seek immediate medical attention if they develop symptoms suggestive of pancreatitis (persistent, severe abdominal pain, sometimes radiating to the back) or gallbladder disease Contact their GP or rheumatology team promptly if they develop new symptoms that could indicate either lupus flare or medication complications (signs of infection, new rashes, joint swelling) Never adjust or discontinue lupus medications without medical guidance, even if experiencing side effects from Wegovy Report any difficulty taking oral medications due to nausea, as this may affect immunosuppressant levels If concerning symptoms develop, treatment should be reviewed promptly
GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting